James R. Gibson II

See Remarks

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 1 saleMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 1 sale

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€1.9M

Latest filing published 08 Oct 2026 for Pacific Biosciences of California, INC., €525k. Read the official filing

Filing timeline

BuySale

James R. Gibson II

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

James R. Gibson II: trading record in brief

This profile gathers the share dealings of James R. Gibson II in Pacific Biosciences of California, Inc. Between 31 March 2025 and 6 October 2026, the trades on record add up to 5 filings.

The open-market record consists of 2 sales worth €1.9M, with no purchase. Other entries cover 2 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 2 sales.

Most recently, on 8 October 2026, the filings show an option exercise worth €525k in Pacific Biosciences of California, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.